TY - JOUR
T1 - Ischemic stroke, part 2
T2 - Optimal treatment and prevention
AU - Bruno, A.
N1 - Copyright:
Copyright 2004 Elsevier B.V., All rights reserved.
PY - 1993
Y1 - 1993
N2 - The goal of medical treatment during acute cerebral infarction is to enhance thrombolysis and inhibit the chemical alterations associated with cell death. Treatment includes avoidance of blood pressure reduction, blood glucose control, possible anticoagulation with IV heparin, and sometimes reduction of cerebral edema. Optimal treatment thereafter depends on the result of patient evaluation. Uncontrolled vascular risk factors (eg, hypertension, smoking, and diabetes) should be treated. Aspirin and ticlopidine reduce the risk of recurrent ischemic stroke. In patients with nonrheumatic atrial fibrillation, anticoagulation with warfarin reduces the risk of embolic events. Carotid endarterectomy is superior to medical management alone in reducing the risk of stroke in patients with >70% symptomatic extracranial carotid stenosis.
AB - The goal of medical treatment during acute cerebral infarction is to enhance thrombolysis and inhibit the chemical alterations associated with cell death. Treatment includes avoidance of blood pressure reduction, blood glucose control, possible anticoagulation with IV heparin, and sometimes reduction of cerebral edema. Optimal treatment thereafter depends on the result of patient evaluation. Uncontrolled vascular risk factors (eg, hypertension, smoking, and diabetes) should be treated. Aspirin and ticlopidine reduce the risk of recurrent ischemic stroke. In patients with nonrheumatic atrial fibrillation, anticoagulation with warfarin reduces the risk of embolic events. Carotid endarterectomy is superior to medical management alone in reducing the risk of stroke in patients with >70% symptomatic extracranial carotid stenosis.
UR - http://www.scopus.com/inward/record.url?scp=0027232831&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0027232831&partnerID=8YFLogxK
M3 - Short survey
C2 - 8449420
AN - SCOPUS:0027232831
SN - 0016-867X
VL - 48
SP - 37
EP - 54
JO - Geriatrics
JF - Geriatrics
IS - 3
ER -